4.6700
+0.3900
+(9.11%)
At close: January 13 at 4:00:01 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -23.6 | -9.2 |
| Low Estimate | 0 | 0 | -23.6 | -9.2 |
| High Estimate | 0 | 0 | -23.6 | -9.2 |
| Year Ago EPS | -18 | -22.4 | -64.8 | -23.6 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 1.07M | 1.4M |
| Low Estimate | -- | -- | 1.07M | 1.4M |
| High Estimate | -- | -- | 1.07M | 1.4M |
| Year Ago Sales | -- | -- | 895.48k | 1.07M |
| Sales Growth (year/est) | -- | -- | 19.60% | 30.72% |
Earnings History
| Currency in USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -18.8 | -13.8 | -19.6 | -12.4 |
| EPS Actual | -18 | -22.4 | -15.6 | -9.6 |
| Difference | 0.8 | -8.6 | 4 | 2.8 |
| Surprise % | 4.26% | -62.32% | 20.41% | 22.58% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -23.6 | -9.2 |
| 7 Days Ago | 0 | 0 | -30 | -19.4 |
| 30 Days Ago | 0 | 0 | -35 | -29.6 |
| 60 Days Ago | 0 | 0 | -35 | -29.6 |
| 90 Days Ago | 0 | 0 | -35 | -29.6 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MYNZ | -- | -- | 63.58% | 61.02% |
| S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 11/25/2024 |
| Reiterates | Cantor Fitzgerald: Neutral | 4/12/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/6/2024 |
| Downgrade | Cantor Fitzgerald: Overweight to Neutral | 11/21/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/20/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/26/2023 |
Related Tickers
DGX Quest Diagnostics Incorporated
154.02
+1.47%
CSTL Castle Biosciences, Inc.
26.15
-13.55%
TTOO T2 Biosystems, Inc.
0.3200
0.00%
APDN Applied DNA Sciences, Inc.
0.1934
-2.18%
CHEK Check-Cap Ltd.
1.5000
-1.96%
GH Guardant Health, Inc.
38.10
+3.80%
ISPC iSpecimen Inc.
2.6800
0.00%
STIM Neuronetics, Inc.
2.3400
+36.84%
PRPH ProPhase Labs, Inc.
0.6490
0.00%
PSNL Personalis, Inc.
5.35
-4.29%